Summary:
The Multidisciplinary Association for Psychedelic Studies (MAPS) Canada is a registered, charitable, non-profit, Canadian organization. MAPS Canada was legally incorporated on July 11, 2011 with the goal of supporting MAPS USA; specifically, the MDMA phase two study which was a multi-country study and a site was being planned for Vancouver, Canada. We are committed to planning, conducting and publishing scientific research and education supporting the beneficial uses of psychedelic medicines, including treatment for medical conditions, neuroscience, creativity and spirituality. Supported by rigorous scientific evaluation of risks and benefits and through partnerships with academic, health, hospital and community organizations, MAPS Canada envisions a world where psychedelic therapies are legally and widely available.